Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

16 Jan, 2018, 07:09 GMT APRINOIA Therapeutics Closes US$11 Million Series B Financing to Advance Its Tau PET Imaging Tracer and Tau Therapeutic Programs for Alzheimer's Disease

APRINOIA Therapeutics Inc., a clinical-stage neuroscience biotech company, focuses on tau, alpha-synuclein, and novel targets for neurodegenerative...


15 Jan, 2018, 07:00 GMT Norgine's PLENVU® (NER1006) Receives Austrian, Australian, French, Irish, Italian and Portuguese Approvals for Bowel Cleansing in Adults Prior to Any Procedure Requiring a Clean Bowel

- PLENVU® is the first 1-litre PEG bowel preparation - PLENVU® is superior to MOVIPREP® in providing high-quality cleansing in...


15 Jan, 2018, 07:00 GMT Moorfields Eye Hospital Dubai Launches New Genetic Service for the UAE and Dr Mariya Moosajee Consults Her First Genetic Eye Disease Patients

Moorfields Eye Hospital Dubai (Moorfields) has launched a new genetic service in the UAE to provide patients with genetic testing and enable...


11 Jan, 2018, 17:00 GMT Western Diet Causes Long-Term Impact on Body's Immune System Even After Dietary Changes

High-fat and high-calorie diet induces an innate immune-triggered inflammatory response similar to that of pathogens, and results in long-term...


11 Jan, 2018, 15:10 GMT Eurocine Vaccines Obtains Authorization to Conduct the Next Study with Immunose™ FLU

Eurocine Vaccines today announced that the company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza...


11 Jan, 2018, 12:00 GMT Norgine Launches Lymphoseek®▼ in Finland and Sweden

Norgine B.V. today announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden. LYMPHOSEEK® is a radiopharmaceutical used for...


11 Jan, 2018, 08:00 GMT SIME Dx Completes EU Horizon 2020 Project Promising Improved Care for Millions of Premature Babies

Project Delivers Strong Clinical Data, IP and Prototype of Rapid Neonatal Lung Maturity Test SIME Dx, a digital molecular medicine company...


10 Jan, 2018, 18:25 GMT Infosys Prize for Six Top Researchers in Science and Humanities

Chief Guest, Nobel Laureate Kip Thorne, felicitates the winners The Infosys Science Foundation (ISF) today honored the winners of the Infosys...


10 Jan, 2018, 09:07 GMT BioProtect Launches an International Multi-Center Clinical Study Following FDA investigational Device Exemption (IDE)

FDA has granted investigational Device Exemption approval (IDE) to conduct a pivotal clinical study examining the use of the ProSpace[TM]...


10 Jan, 2018, 09:00 GMT Engineering Solution from NUST MISIS Scientists to Significantly Decrease Costs of MRI Research

Researchers from the NUST MISIS Engineering Center for Industrial Technologies have developed an innovative technology for the production...


09 Jan, 2018, 14:00 GMT WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity

A pioneering real-world example of how advanced AI can contribute to better medicine, uncovering the roots of rare metabolic syndromes to optimize...


09 Jan, 2018, 09:00 GMT Emotional Brain's FSIAD Products Lybrido and Lybridos show High Efficacy and Safety in Phase 2B Trials

Emotional Brain is pleased to announce the publication of positive phase 2B results in the authoritative Journal of Sexual Medicine. Lybrido and...


09 Jan, 2018, 09:00 GMT Patient Centricity Becomes a Reality with SQN Health

Patient centricity is the aspiration for the healthcare industry. Putting patients in control of their own health journey and empowering them to...


09 Jan, 2018, 07:29 GMT BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors as a potential cornerstone...


08 Jan, 2018, 14:15 GMT Endotronix Announces Successful First-in-Human Implantation of the Cordella Pulmonary Artery Pressure Sensor and Initiation of the SIRONA Clinical Trial

Endotronix, Inc., a medical technology company providing device and digital health solutions for heart failure management, today announced...


05 Jan, 2018, 07:51 GMT Cantargia Receives Patent Approval in China for Antibody Treatment Against IL1RAP in Solid Tumours

Cantargia AB ("Cantargia") announces that the Chinese patent office, the State Intellectual Property Office ("SIPO"), has formally approved the...


05 Jan, 2018, 05:01 GMT ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's...


04 Jan, 2018, 10:25 GMT Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing tumor-directed immunotherapies, today announced that the...


04 Jan, 2018, 09:22 GMT Cantargia Receives Notice of Allowance From USPTO for Expanded Protection in Treatment of Solid Tumours

Cantargia AB ("Cantargia") has been notified that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the...


04 Jan, 2018, 09:00 GMT Hycor Biomedical Applies CE Mark to IVD Allergy Instrument: NOVEOS™

Hycor Biomedical, a leading manufacturer of in vitro diagnostic products for allergy and autoimmune testing, announced today that it has applied...


04 Jan, 2018, 08:00 GMT Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS® for the Management of Post-operative Nausea & Vomiting

If approved, BAREMSIS would be the first antiemetic with an indication for: - rescue treatment of PONV after failed prophylaxis, and -...


04 Jan, 2018, 08:00 GMT Heptares Scientists Solve Structure of Complement C5a Receptor, an Important Drug Target for Inflammatory and Neurodegenerative Diseases, and Cancer

Publication in Nature highlights opportunities to target C5a receptor with selective small molecules via novel mechanism of action Sosei Group...


04 Jan, 2018, 02:24 GMT Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery

- Complex structure of a class B GPCR bound to an analogue of its endogenous ligand ignites new excitement in GPCR research Class B G...


04 Jan, 2018, 00:00 GMT BlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

6-Month OPTIMIST Study show BlueWind Renova™ is a safe, minimally invasive system that offers significant improvements for Over Active...


03 Jan, 2018, 14:00 GMT Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine

Undiagnosed sleep apnea is highly prevalent among hospital patients, and treating it after they're discharged can improve their chances of...